Ebert R, Creutzfeldt W
Diabetologia. 1980 Sep;19(3):198-204. doi: 10.1007/BF00275269.
The influence of impaired digestion on nutrient induced release of gastric inhibitory polypeptide (GIP) and insulin have been investigated in patients with chronic pancreatitis. All patients had massive steatorrhea (> 25 g/24 h), and glucose intolerance. A standard liquid test meal comprising fat and glucose were ingested with or without pancreatic enzyme substitution (9.0 g pancreatin). In the presence of pancreatin the response of serum levels of GIP to the test meal was significantly enhanced (81.2 vs 194.5 microgram/l X 180 min). Concurrently, the insulin response was augmented (3.4 vs 6.4 U/l X 180 min), resulting in improved glucose tolerance. Addition of pancreatin also significantly augmented the GIP response to oral fat (100 g), but not to oral glucose (100 g). In patients with pancreatogenic steatorrhea the insulin response to an IV glucose infusion (0.7 g/kg/h for 90 min) was augmented by oral fat only after addition of 9.0 g pancreatin to the fat load (3.5 vs 7.3 U/l X 180 min). After restoration of the GIP response to fat by pancreatin, the inhibitory effect of IV glucose on fat-induced GIP increase was restored. These data indicate that the GIP response to a mixed meal or triglycerides is dependent on the absorption of nutrients. In patients with chronic pancreatitis improvement of pancreatogenic insufficiency reverses the impaired GIP response, restores the incretin effect of fat, and improves glucose tolerance.
在慢性胰腺炎患者中,研究了消化功能受损对营养物质诱导的胃抑制多肽(GIP)和胰岛素释放的影响。所有患者均有大量脂肪泻(>25 g/24 h)和糖耐量异常。摄入含脂肪和葡萄糖的标准液体试验餐,同时或不进行胰酶替代(9.0 g胰酶)。在使用胰酶的情况下,血清GIP水平对试验餐的反应显著增强(81.2对194.5微克/升×180分钟)。同时,胰岛素反应增强(3.4对6.4 U/升×180分钟),导致糖耐量改善。添加胰酶也显著增强了GIP对口服脂肪(100 g)的反应,但对口服葡萄糖(100 g)无增强作用。在胰腺性脂肪泻患者中,仅在脂肪负荷中添加9.0 g胰酶后,口服脂肪才增强了对静脉输注葡萄糖(0.7 g/kg/h,持续90分钟)的胰岛素反应(3.5对7.3 U/升×180分钟)。通过胰酶恢复GIP对脂肪的反应后,静脉注射葡萄糖对脂肪诱导的GIP增加的抑制作用得以恢复。这些数据表明,GIP对混合餐或甘油三酯的反应取决于营养物质的吸收。在慢性胰腺炎患者中,胰腺功能不全的改善可逆转受损的GIP反应,恢复脂肪的肠促胰岛素效应,并改善糖耐量。